Diabetes

The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Australia.

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Taiwan.

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in South Korea.

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 2004.

The diabetes diagnostics market in Japan is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012(CAGR period), with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

The diabetes diagnostics market in China is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2005 to 2012{CAGR period}, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

The Australian diabetes diagnostic market on a whole is a mature market. The laboratory segment is also in a highly mature stage characterized by lower profit margins, high number of market participants, decreasing prices, and high competitiveness. The POCT segment features in the high growth stage of the market development process characterized b...